INTRODUCTION 40 41
Shiga toxigenic Escherichia coli (STEC) cause severe gastrointestinal infections in 42 humans, which may progress to hemorrhagic colitis and the hemolytic uremic syndrome 43 (HUS), a life-threatening combination of microangiopathic hemolytic anemia, 44 thrombocytopenia and renal failure (14, 19) . These clinical manifestations have long been 45 considered to be largely attributable to effects of Shiga toxin (Stx) on microvascular 46 endothelial cells (19). However, some STEC strains produce an additional AB 5 cytotoxin 47 named subtilase cytotoxin (SubAB), which has the potential to make a major contribution to 48 the pathogenesis of HUS in its own right. SubAB was initially detected in a locus of 49 enterocyte effacement-negative O113:H21 STEC strain responsible for a small outbreak of 50 HUS in South Australia (17, 18), but it is also produced by numerous other disease-causing 51 STEC serotypes (8, 16, 17) . SubAB is extraordinarily toxic for eukaryotic cells, and its 52 mechanism of action involves highly specific A-subunit-mediated proteolytic cleavage of the 53 essential endoplasmic reticulum (ER) chaperone BiP (GRP78) (15). This triggers a massive 54 ER stress response, ultimately leading to apoptosis (11, 12, 26) . 55
Our recent in vitro studies have shown that SubAB also increases tissue factor-56 dependent factor Xa generation by cultured human umbilical vein endothelial cells and human 57 macrophages, suggesting a direct pro-coaggulant effect (25). In mice, intraperitoneal (i.p.) 58 injection of purified SubAB causes microangiopathic hemolytic anemia, thrombocytopenia 59 and renal impairment, characteristics typical of Stx-induced HUS (24). Histological 60 conjugated streptavidin and Annexin-V-FITC. All incubations were carried out in dark, on 127 ice at 4°C for 30 min. Labelled cells were analysed immediately on a FACscan flow 128 cytometer. Fluorescence of FITC-Annexin V was read via channel FL1 and leukocyte marker 129 related fluorescence (PE) was detected via channel FL2. 130
In vitro binding of SubAB to leukocytes. Mouse peritoneal or blood leukocytes 131
were freshly harvested and pooled from 2 normal mice, as described above. Leukocytes were 132 then washed and resuspended in complete leukocyte culture medium (RPMI1640 133 supplemented with 10% fetal calf serum, 2 mM glutamine, 100 µg/ml of penicillin and 134 streptomycin). One million peritoneal or blood leukocytes, resuspended in 500 µl complete 135 leukocyte culture medium containing 1 µg/ml OG-labelled SubAB or labelled control proteins 136 (OG-SubA, OG-SubB, OG-SubAA272B and OG-ovalbumin [unlabelled ovalbumin was 137 obtained from Sigma]), were cultured at 37°C in 95% air/5% CO2 for 90 min. Cells cultured 138 in medium only (no OG-protein added) were used as negative controls. Labelling of cells was 139 stopped by addition of 500 µl of 4% formaldehyde and the cells were washed with ice cold 140 PBS and then analyzed by flow cytometry, or underwent further leukocyte surface marker 141 labelling as described above. 142
Statistical analysis. Statistical analysis was performed using GraphPad Prism 3.03 or 143
Microsoft Excel 2003 software. FACS data are presented as mean ± SEM and differences 144 between cells from control and SubAB-treated mice were analysed using Student's unpaired 145 t-test. P < 0.05 was considered significant. 146
RESULTS

149
Binding of SubAB by peritoneal leukocytes in vivo. Initial experiments used flow 150 cytometry to examine binding and/or uptake of SubAB by murine peritoneal leukocytes at 151 various times after i.p. injection of 5 µg toxin (Fig. 1) . Bound or internalized toxin was 152 detected using a polyclonal rabbit antibody raised against the A subunit of the toxin (SubA). 153
SubAB binding/uptake was maximal at 6 h post-injection, at which time approximately 82% 154 of the leukocyte population was labelled; at 16 and 24 h, labelling was still substantial (58% 155 and 65% of the total population, respectively). The specificity of the rabbit anti-SubA was 156
confirmed by comparing the FACS scan of peritoneal leukocytes from control (non-SubAB-157 treated) mice after labelling with anti-SubA, or from 6 h toxin-treated mice after labelling 158 with non-immune serum, with those from 6 h toxin-treated mice labelled with anti-SubA 159 (result not shown). 160
To examine whether the toxin bound preferentially to specific leukocyte subsets, 161 peritoneal leukocytes harvested 6 h post injection were double-labelled with anti-SubA and 162 various leukocyte marker-specific monoclonal antibodies (Fig. 2) SubAB could directly bind all leukocyte subsets after i.p. injection. As independent 170 verification, we examined the capacity of OG-labelled SubAB and similarly labelled control 171 proteins to interact with murine leukocytes in vitro. Peritoneal and peripheral blood 172 leukocytes harvested from normal mice were co-cultured for 90 min with 1 µg/ml OGdetectable labelling of leukocytes incubated with OG-SubA or OG-ovalbumin. This indicates 177 that interaction with leukocytes derived from normal mice is absolutely dependent on the 178 presence of the B subunit of the toxin. OG-SubAB-treated blood leukocytes were also double-179 labelled with the leukocyte marker-specific monoclonal antibodies and analysed by flow 180 cytometry (percentage labelling for each subset was calculated as described above for Fig. 2) . 181
As seen previously for peritoneal leukocytes harvested from SubAB-injected mice, there was 182 significant binding of labelled toxin to CD4+ and CD8+ T lymphocytes, B lymphocytes and 183 neutrophils (98.1%, 94.5%, 82.3%, and 99.8% of the respective leukocyte sub-populations 184
were positive for OG-SubAB binding) (Fig. 4) . 185
Effect of injection of SubAB on leukocyte distribution. Total numbers and 186
distribution of leukocyte sub-populations were then examined in the blood, peritoneal cavity 187 and spleens of mice at various times after SubAB injection (Fig. 5 ). Toxin treatment 188 significantly increased the total numbers of peritoneal and blood leukocytes, which peaked at 189 24 h. However, a significant decrease in splenic leukocytes was evident from 6 h. 190
Immuno-fluorescence labelling and FACS analysis ( percentage of total blood leukocytes from 4.55% at 0 h to 8.94% at 24 h (P < 0.05). In the 195 spleen, a marked drop in the numbers of both CD4+ and CD8+ sub-populations from 6 h (P < 196 0.01 in both cases) largely accounted for the decrease in total splenic leukocytes. The number 197 of splenic B lymphocytes also decreased, although this was only statistically significant at 48 198 h (P < 0.05). In the peritoneal cavity where SubAB was injected, the total numbers of both 199 neutrophils and macrophages increased swiftly. Significant neutrophil recruitment was 200 evident from 1 h and was highest at 48 h (P < 0.01 for all time points). Macrophage numbers 201
were significantly elevated at 6 h and peaked at 24 h (P < 0.01 in both cases). numbers, but also in the mean level of expression of the surface protein Ly-6G (Fig. 7) , an 206 indication of neutrophil maturation. 207
Effect of SubAB on leukocyte apoptosis. Double labelling with Annexin V and PI 208 was used to investigate the total rate of apoptosis and necrosis in the various niches after toxin 209 treatment (Fig. 8) . For the total leukocyte population, rates of necrosis remained low (below 210 7.4%) in all niches throughout the experiment. However, apoptosis rates were elevated from 211 1 h after toxin treatment, and reached statistical significance for total blood leukocytes at 6 h 212 and 24 h (P < 0.05). 213 Double labelling with Axinnexin V and anti-leukocyte markers was used to establish 214 apoptosis rates in different sub-populations of leukocytes (Fig. 9) . Apoptosis rates of blood 215 CD4+ T cells and B220+ B cells were significantly elevated over baseline at 1 and 6 h. 216
Apoptosis rates of splenic CD4+ T cells and B220+ B cells were also elevated at these time 217 points, reaching statistical significance at 6 h and 1 h, respectively. In blood and the 218 peritoneal cavity, apoptosis of macrophages was significantly elevated at 1 h, but not 219 thereafter. Interestingly, there was a marked difference in the baseline level of neutrophil 220 apoptosis in blood versus the peritoneal cavity (1% versus 34%, respectively). However, there 221 was a marked and sustained reduction in the apoptosis rate of peritoneal neutrophils after 222 toxin treatment, diminishing to approximately 8-10% at 6, 24 and 48 h (P < 0.05 in all cases). 223
In contrast, the apoptosis rate of blood neutrophils, like most of the other leukocytes 224 examined, was increased by toxin treatment from the low baseline level, reaching statistical 225 significance at 6 h post SubAB injection (P < 0.05). study. Effects of toxin injection were not confined to the peritoneal cavity, with significant 258 leukocytosis in the blood at 24 h. All leukocyte sub-populations measured were elevated at 259 this time point, although the greatest relative increases over untreated baseline levels were 260 seen for T and B lymphocytes. Nevertheless, blood neutrophil numbers were significantlysurface of these cells, as well as on peritoneal neutrophils. Ly-6G expression level has been 263 reported to be directly proportional to neutrophil differentiation, maturation and IL-1 receptor 264 expression, and hence is indicative of activation (1). Indeed we have shown that treatment of 265 U937 cells with SubAB up-regulates expression of TNFα and IL-1β in addition to the CXC 266 chemokines mentioned above (manuscript in preparation). It has long been known that 267 neutrophil leukocytosis correlates with poor outcome in HUS patients, and activated 268 neutrophils play a key role in pathogenesis as mediators of endothelial injury (6). 269
The toxin-induced leukocytosis observed in the present study was accompanied by a 270 marked reduction in numbers of splenic lymphocytes, most notably CD4+ and CD8+ T cells. 271
The total numbers of splenic leukocytes decreased more than two-fold within 6 h of toxin 272 treatment, which is consistent with our previous histological observation of profound splenic 273 atrophy and depletion of lymphocytes in the white pulp (24). This reduction was presumably 274 a consequence of the combination of leukocyte migration into the peripheral circulation and 275 significantly increased rates of apoptosis of both T and B lymphocytes. Increased apoptosis 276 was a widespread toxin-induced phenomenon, and was seen for all leukocyte sub-populations 277 and at all sites examined. The only apparent exception to this was the significant decrease in 278 apoptosis rates in peritoneal neutrophils, from an initially high baseline (0 h) level of 34% to 279 8% at 6 h post-injection. However, during this period there is massive recruitment of 280 neutrophils from the peripheral circulation and presumably also the bone marrow, with total 281 numbers in the peritoneal cavity increasing roughly 10-fold. Unsurprisingly, the level of 282 apoptosis in peritoneal neutrophils at 6 h closely reflects that seen in peripheral blood 283 neutrophils at the same time-point. 
